http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0013190-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-115
filingDate 2000-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f98cdcd66dbff53d187407fef894530b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03d2c6c017dcfa4f097bfffc76f2e8e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_864ae3426f4bf3dd984bbb163ec35384
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0743dc10bb693073817005ea56f7bfd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf3029effe33892bd477de10f0b202be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_187f6089bc5790522bead906ec615ce3
publicationDate 2002-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0013190-A
titleOfInvention Attenuated bovine human chimeric parainfluenza virus (pvi) vaccines
abstract "HUMAN-BOVINE ATTENUATED CHIMERIC VINYL VIRUS VACCINES (PIV)". Human-bovine chimeric parainfluenza viruses (PIVs) are infectious and attenuated in humans and other mammals and are useful individually or in combination in vaccine formulations to induce an anti-PIV immune response. Isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigen are also provided, which includes a partial or complete human or bovine PIV antigen genome or antigenome combined or integrated with one or more of the heterologous genes or genomic segment of a different PIV. The chimeric human-bovine PIV of the invention includes an "antecedent" genome or partial or complete PIV antigenome derived from or standardized after a human or bovine PIV virus, combined with one or more heterologous genes or genomic segments of a different PIV virus to form the genome or antigenome of the chimeric human-bovine PIV. In certain aspects of the invention, the chimeric PIV incorporates an antecedent genome or partial or complete human PIV antigenome combined with one or more heterologous genes or genomic segments from a bovine PIV, according to which the resulting chimeric virus is attenuated in virtue restriction in the host range. In an alternative configuration, the chimeric human-bovine PIV incorporates an antecedent PIV genome or partial or complete bovine antigenome combined with one or more heterologous genes or genomic segment from a human PIV gene encoding a human PIV immunogenic protein, domain of protein or epitope, for example, encoded by PIV glycoprotein and / or HN genes or genomic segments. The chimeric human-bovine PIV of the invention are also useful as vectors for the development of vaccines against other pathogens. A variety of additional mutations and nucleotide modifications are provided within the chimeric human-bovine PIV of the invention resulting in a desired phenotype and structural effects.
priorityDate 1999-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420207533
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6325

Total number of triples: 33.